- CIIX CEO Warren Wang reported that MicroCap Conference attendees showed interest in the company’s presentation
- In a MoneyTV interview, Wang expressed optimism about the long-range sales of CBD; CIIX will focus on the CBD cosmetics sector
- CIIX reported a 175 percent YOY sales increase for FY2019; industrial hemp and CBD liquor products showed sharp gains
ChineseInvestors.com Inc. (OTCQB: CIIX) CEO Warren Wang said in a MoneyTV interview with host Donald Baillargeon that he was pleased with the reaction to the company’s presentation at the MicroCap Conference, held recently at the Essex House in New York. The presentation was given by Alex Hamilton, CFO of CIIX subsidiary Biotech CBD Inc. (http://cnw.fm/x5iZm).
The conference was designed to bring together high-level institutional and retail investors with publicly held small- and micro-cap companies. Wang noted that he is optimistic about the long-term growth of CBD sales and said that, moving forward, the company plans to focus on cosmetics in the category. According to New Frontier Data, the U.S. hemp CBD market is expected to triple in value by 2022. Likewise, according to Hemp Industry Daily market projections, the national market for hemp-derived CBD is expected to balloon to $7 billion by 2023 (http://cnw.fm/aHK7u).
In addition, CIIX reported sharp gains of 175 percent year-over-year for its FY2019, ended in May 2019. That gain was generated by FY2019 sales of $6,476,442, as compared to $2,353,331 in FY2018, according to its 10-K SEC filing (http://cnw.fm/kfu9H). The increase was driven by industrial-hemp and CBD-liquor product sales of $4,189,935 in FY2019, as compared to $378,984 in FY2018 (http://cnw.fm/YF7c1). Investor relations, a core business for the company, generated gains as well, with sales totaling $1,336,402 in FY2019, as compared to $968,282 the prior year.
Earlier, Wang projected that CIIX sales will reach $11 million to $12 million in FY2020 – the 12 months ending in May 2020. That projection was made during a wide-ranging interview on the Redchip Money Report with host Dave Gentry, broadcast on YouTube. The company has long been reaching a Chinese-speaking audience in the United States and Canada with investment information on issues ranging from cryptocurrency to CBD.
In the same interview, Wang also noted that investors should know that CIIX is seeking to expand its future business. “We are going to do some merger/acquisition to expand our business in the Asian region,” he told the host.
CIIX is a diverse company driven not only by educational services but also by sales of cosmetics, hemp wine and CBD. CIIX offers its audience of Chinese-speaking investors real-time market commentary, analysis and education-related services in Chinese character language sets.
For more information, visit the company’s website at www.ChineseInvestors.com
NOTE TO INVESTORS: The latest news and updates relating to CIIX are available in the company’s newsroom at http://cnw.fm/CIIX
CBDWire (CBDW) is a specialized information provider focused on (1) reporting CBD-related news and updates, (2) releasing CBDNewsBreaks crafted to keep investors abreast of the latest and greatest in the CBD market, (3) refining and enhancing corporate press releases, (4) delivering end-to-end distribution and social media services to client-partners and (5) constructing effective corporate communication solutions based on the unique requirements of CBD companies. CBDW is exclusively positioned in the burgeoning CBD sector with a proven team of journalists and researchers working to deliver high quality content to an expansive target audience of investors, consumers and industry news outlets. Our dissemination network of over 5,000 downstream distribution points allows us to deliver unparalleled reach, visibility and recognition to companies operating in both cannabidiol and the wider cannabis space. CBDWire (CBDW) is where CBD news, content and information converge.
To receive instant SMS alerts, text CBDWire to 21000 (U.S. Mobile Phones Only)
For more information please visit https://www.cbdwire.com
Do you have a questions or are you interested in working with CNW? Ask Our Editor